1772 less than 50% of one month relative dose intensity is the poor prognostic factor of sorafenib therapy for cytokine refractory renal cell carcinomaAtsunari Kawashima,Hitoshi Takayama,Yasuyuki Arai,Go Tanigawa,Mikio Nin, Jiro Kajikawa, Tetsuo Imazu, Tatsuya Kinoshita,Yutaka Yasunaga,Hitoshi Inoue,Shingo Takada,Kenji Nishimura, Nobukazu Murosaki, Shigeru Saiki, Nobuyuki Fujimoto,Mototaka Sato,Koji Hatano,Yasuyuki Kojima,Masatoshi Mukai,Akira NagaharaJOURNAL OF UROLOGY（2011）引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
